Company: HROW
Filing Date: 2025-11-10
Form Type: 10-Q
Source: 0001493152-25-021562
Chunk: 24

Company: HARROW, INC.
Filing Date: 2025-11-10
Form: 10-Q
Item: Item 1
Chunk 24
---
 

    For the Three Months Ended  
    For the Nine Months Ended 

    September 30,  
    September 30, 

    2025  
    2024  
    2025  
    2024 
  
    Product sales, net 
    $71,497,000  
    $49,019,000  
    $182,899,000  
    $132,398,000 
  
    Other revenues 
     141,000  
     238,000  
     312,000  
     385,000 
  
    Total revenues 
    $71,638,000  
    $49,257,000  
    $183,211,000  
    $132,783,000 

Deferred
revenue and customer deposits at September 30, 2025 and December 31, 2024 were $345,000 and $44,000, respectively. All deferred revenue
and customer deposit amounts at December 31, 2024 were recognized as revenue during 2025.

NOTE
4. INVENTORIES

Inventories
are comprised of finished compounded formulations, over-the-counter and prescription retail pharmacy products, branded pharmaceutical
products, including those held at the Company’s 3PL partner, related laboratory supplies and active pharmaceutical ingredients.
The composition of inventories as of September 30, 2025
and December 31, 2024 was as follows:

 SCHEDULE
OF INVENTORIES

    September 30,
 2025  
    December 31,
 2024 
  
    Raw materials 
    $5,212,000  
    $5,362,000 
  
    Work in progress 
     842,000  
     858,000 
  
    Finished goods 
     6,780,000  
     4,482,000 
  
    Total inventories 
    $12,834,000  
    $10,702,000 

NOTE
5. PREPAID EXPENSES AND OTHER CURRENT ASSETS

Prepaid
expenses and other current assets at September 30, 2025 and December 31, 2024 consisted of the following:

 SCHEDULE
OF PREPAID EXPENSES AND OTHER CURRENT ASSETS

    September 30, 
2025  
    December 31, 
2024 
  
    Prepaid insurance